| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5fb58392cab8f7aa07f0940d7e6c52b4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-275
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1635 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 |
| filingDate |
2006-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_faf9cde741d33a0e11898d1c27a2d183
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a20d1156ab2a094e44e5edcd13fafbab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f41bd15a4dd4201df9b596d0af0a8ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02c6eb5a1509d0cbbe72b4d5cd7456d5 |
| publicationDate |
2007-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007025182-A3 |
| titleOfInvention |
Drug compositions containing controlled release hypromellose matrices |
| abstract |
This invention is directed to a controlled release formulation for an oral dosage form that is formulated into a swellable, hydrophilic matrix. The controlled release formulation contains a mixture of hypromellose and polyvinyl acetate phthalate and allows pharmaceutically active ingredients combined therewith to be released in a controlled release manner. |
| priorityDate |
2005-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |